Clinical trial

Atorvastatin and LDL Profile in Non-Insulin Dependent Diabetes Mellitus

NCT00640549

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Atorvastatin Normalized identity: atorvastatinView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Atorvastatin and LDL Profile in Non-Insulin Dependent Diabetes Mellitus

Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2003-03-01

PhasePHASE4

Conditions

Hyperlipidemiaverified · MONDO: hyperlipidemia

Diabetes Mellitus, Type 2verified · MONDO: type 2 diabetes mellitus

Non-Insulin Dependent Diabetes Mellitusverified · MONDO: type 2 diabetes mellitus

Interventions

AtorvastatinDRUG · verified · RxNorm: atorvastatin

PlaceboDRUG

Sponsors & collaborators

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.lead sponsor

Mapped research locations

DresdenGermany1 EssenGermany1 HeidelbergGermany1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00640549 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.